Abstract:Data quality in global metabolomics is of great importance for biomarker discovery and system biology studies. However, comprehensive metrics and methods to evaluate and compare the data quality of global metabolomics data sets are lacking. In this work, we combine newly developed metrics, along with well-known measures, to comprehensively and quantitatively characterize the data quality across two similar liquid chromatography coupled with mass spectrometry (LC–MS) platforms, with the goal of providing an efficient and improved ability to evaluate the data quality in global metabolite profiling experiments. A pooled human serum sample was run 50 times on two high-resolution LC-QTOF-MS platforms to provide profile and centroid MS data. These data were processed using Progenesis QI software and then analyzed using five important data quality measures, including retention time drift, the number of compounds detected, missing values, and MS reproducibility (2 measures). The detected compounds were fit to a γ distribution versus compound abundance, which was normalized to allow comparison of different platforms. To evaluate missing values, characteristic curves were obtained by plotting the compound detection percentage versus extraction frequency. To characterize reproducibility, the accumulative coefficient of variation (CV) versus the percentage of total compounds detected and intraclass correlation coefficient (ICC) versus compound abundance were investigated. Key findings include significantly better performance using profile mode data compared to centroid mode as well quantitatively better performance from the newer, higher resolution instrument. A summary table of results gives a snapshot of the experimental results and provides a template to evaluate the global metabolite profiling workflow. In total, these measures give a good overall view of data quality in global profiling and allow comparisons of data acquisition strategies and platforms as well as optimization of parameters.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c01493?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c01493</a>.Flow chart to process the raw LC–MS data (Figure S1), detected compounds and missing values versus compound abundance (Figure S2), the Pearson correlation coefficient versus compound abundance (Figure S3), missing-value performance for the reduced number of samples (Figure S4), detected compounds and missing values versus compound abundance for five QCs (Figure S5), the percentage of compounds versus CV (Figure S6), the 3-D plot of same versus log<sub>10</sub>(abundance) for five QCs, ICC values versus the percentage of compounds, the 3-D plot of same versus CV for five QCs (Figure S7), detected compounds and missing values versus compound abundance for five QCs (Figure S8), and the Pearson correlation coefficient versus compound abundance for five QCs (Figure S9) (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c01493/suppl_file/ac0c01493_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Quality Assessment of LC-MS Metabolomic Data

Untargeted LC–MS Data Preprocessing in Metabolomics

Evaluation of Normalization Methods for Analysis of LC-MS Data

Five Easy Metrics of Data Quality for LC–MS-Based Global Metabolomics

Harmonized quality assurance/quality control provisions to assess completeness and robustness of MS1 data preprocessing for LC-HRMS-based suspect screening and non-targeted analysis

High Tolerance to Instrument Drifts by Differential Chemical Isotope Labeling LC-MS: A Case Study of the Effect of LC Leak in Long-Term Sample Runs on Quantitative Metabolome Analysis.

Analytical Opportunities and Challenges for Data Handling with Chemometrics Strategies from LC-MS Based Food Metabolomics

Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies

Current Practices in LC-MS Untargeted Metabolomics: A Scoping Review on the Use of Pooled Quality Control Samples

Analytical challenges of untargeted GC-MS-based metabolomics and the critical issues in selecting the data processing strategy

Different Software Processing Affects the Peak Picking and Metabolic Pathway Recognition of Metabolomics Data.

A Data Preprocessing Strategy for Metabolomics to Reduce the Mask Effect in Data Analysis

Large-scale Untargeted LC-MS Metabolomics Data Correction Using Between-Batch Feature Alignment and Cluster-Based Within-Batch Signal Intensity Drift Correction.

Mass spectrometry-based metabolomics: a guide for annotation, quantification and best reporting practices

The Great Importance of Normalization of LC–MS Data for Highly‐accurate Non‐targeted Metabolomics

Advances in high throughput LC/MS based metabolomics: A review

Towards Unbiased Evaluation of Ionization Performance in LC-HRMS Metabolomics Method Development

Evaluating Protocols for Reproducible Targeted Metabolomics by NMR

Visualization, Quantification, and Alignment of Spectral Drift in Population Scale Untargeted Metabolomics Data

Simulated LC-MS Data Set for Assessing the Metabolomics Data Processing Pipeline Implemented into MVAPACK

Theory and Instrumentation of Mass Spectrometry and its Application to Drug Metabolism